Clinical Trial Update: A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating concomitant camrelizumab with chemoradiation for locally advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN